To compare the available literature regarding the use of long-acting muscarinic antagonist (LAMA)/long-acting β agonists (LABA) and inhaled corticosteroid (ICS)/LABA combination inhaler therapy in chronic obstructive pulmonary disease (COPD) maintenance therapy management.